Coya Therapeutics (COYA) Assets Average (2023 - 2026)
Coya Therapeutics (COYA) posted Assets Average of $51.6 million for Q1 2026, up 25.89% sequentially from $41.0 million in Q4 2025, and up 24.74% YoY from $41.4 million in Q1 2025.
Coya Therapeutics (COYA) Assets Average (2023 - 2026) Analysis & Trends
Coya Therapeutics has reported Assets Average for 4 years, with the latest figure at $51.6 million in Q1 2026.
- Quarterly Assets Average rose 24.74% year-over-year to $51.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51.6 million (up 24.74% YoY) and the FY2025 annual result came in at $47.1 million, up 10.15% from the prior year.
- Assets Average advanced to $51.6 million in Q1 2026 per COYA's latest filing, from $41.0 million in the prior quarter.
- Over five years, Assets Average peaked at $51.6 million in Q1 2026 and troughed at $12.9 million in Q1 2023.
- A 4-year average of $32.8 million and a median of $37.7 million in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2024 and 2025: Assets Average surged 204.7% in 2024, then slipped 13.24% in 2025.
- Over 4 years, Assets Average stood at $26.6 million in 2023, then soared by 50.31% to $39.9 million in 2024, then climbed by 2.62% to $41.0 million in 2025, then advanced by 25.89% to $51.6 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $51.6 million, $41.0 million, and $32.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.57 Bn | 131.72 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 65.44 Bn | 60.25 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.06 Bn | 54.93 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.89 Bn | 28.58 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.11 Bn | 9.72 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 19.82 Bn |
| 10 | Coya Therapeutics | 114.24 Mn | 71.04 Mn | - | 50.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 50.29 Mn |
| Mar 31, 2026 | 51.61 Mn |
| Dec 31, 2025 | 41.00 Mn |
| Sep 30, 2025 | 32.75 Mn |
| Jun 30, 2025 | 35.93 Mn |
| Mar 31, 2025 | 41.38 Mn |
| Dec 31, 2024 | 39.95 Mn |
| Sep 30, 2024 | 37.75 Mn |
| Jun 30, 2024 | 38.67 Mn |
| Mar 31, 2024 | 39.33 Mn |
| Dec 31, 2023 | 26.58 Mn |
| Sep 30, 2023 | 13.18 Mn |
| Jun 30, 2023 | 15.94 Mn |
| Mar 31, 2023 | 12.91 Mn |